Epigral Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

41.55

41.55

41.55

41.55

41.19

Share application money

-

-

-

-

-

Preference share capital

110.00

-

-

-

210.92

Reserves & surplus

1,027.62

684.42

431.66

331.00

240.66

Loan funds

Secured loans

766.14

989.36

626.42

648.93

367.71

Unsecured loans

-

-

-

-

-

Total

1,945.31

1,715.33

1,099.64

1,021.48

860.48

Uses of funds

Fixed assets

Gross block

2,310.66

1,468.73

1,421.11

688.10

498.90

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

506.61

400.90

318.80

247.92

204.18

Net block

1,804.05

1,067.83

1,102.31

440.17

294.72

Capital work-in-progress

158.10

589.25

125.84

691.16

468.25

Investments

20.62

0.05

0.05

-

-

Net current assets

Current assets, loans & advances

449.48

466.53

220.55

142.13

281.25

Less : current liabilities & provisions

486.94

408.33

349.12

251.99

183.74

Total net current assets

-37.46

58.20

-128.56

-109.85

97.51

Miscellaneous expenses not written

-

-

-

-

-

Total

1,945.31

1,715.33

1,099.64

1,021.48

860.48

Notes:

Book value of unquoted investments

20.57

-

0.05

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

293.41

242.60

393.53

82.77

121.92

Number of equity sharesoutstanding (Lacs)

415.50

415.50

415.53

415.53

411.93